Skip to main content

Off/On

Premium

In a new study in Nature Medicine, researchers at the Peter MacCallum Cancer Centre in Australia and their collaborators have found that breast cancer cells metastasize to bone in part by deactivating an immune system response meant to prevent the spread of the disease, says Reuters' Tan Ee Lyn. Using mouse models and by analyzing tissue samples from breast cancer patients, the team found that the IRF7 gene — which controls the production of the immune protein interferon — is turned off in patients whose cancer has metastasized. "Usually when breast cancer cells leave the breast and travel in the bloodstream and into bone marrow, the release of interferons by IRF7 will cause the immune system to recognize those cells and eliminate them," lead author Belinda Parker tells Lyn. "But by losing IRF7, it prevents the stimulation of immune responses and allows those cells to hide from being recognised (and later spread)."

But the researchers also hope that their discovery will allow them to find a way to turn the gene back on. They tried inserting the gene into the cancer cells so they can't turn it off and found that the immune pathways responded and didn't allow the cancer to spread, Lyn says. They also tried treating mice with breast cancer with interferon, which also prevented bone metastases from forming. "Parker said they will study how best to use these two methods on patients in the next few years and plan to have a clinical trial in two to three years," Lyn adds.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.